132 related articles for article (PubMed ID: 34411597)
1. Non-Animal Stabilized Hyaluronic Acid/Dextranomer Gel (NASHA/Dx, Deflux) for Endoscopic Treatment of Vesicoureteral Reflux: What Have We Learned Over the Last 20 Years?
Kirsch AJ; Cooper CS; Läckgren G
Urology; 2021 Nov; 157():15-28. PubMed ID: 34411597
[TBL] [Abstract][Full Text] [Related]
2. Proprietary non-animal stabilized hyaluronic acid/dextranomer gel (NASHA/Dx) for endoscopic treatment of grade IV vesicoureteral reflux: Long-term observational study.
Stenbäck A; Olafsdottir T; Sköldenberg E; Barker G; Stenberg A; Läckgren G
J Pediatr Urol; 2020 Jun; 16(3):328.e1-328.e9. PubMed ID: 32414615
[TBL] [Abstract][Full Text] [Related]
3. [Dextranomer beads in stabilized non-animal sodium hyaluronate gel (NASHA/Dx gel) for vesicoureteral reflux: multi-center study in Japanease patients].
Tanikaze S; Osa Y; Tada M; Goya N; Asanuma H; Yamazaki Y; Shimada K; Sugita Y; Goto T; Yamaguchi T
Nihon Hinyokika Gakkai Zasshi; 2010 Jul; 101(5):676-82. PubMed ID: 20715499
[TBL] [Abstract][Full Text] [Related]
4. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon.
Yu RN; Roth DR
Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825
[TBL] [Abstract][Full Text] [Related]
5. Factors affecting the success of endoscopic treatment of vesicoureteral reflux and comparison of two dextranomer based bulking agents: does bulking substance matter?
Dogan HS; Altan M; Citamak B; Bozaci AC; Koni A; Tekgul S
J Pediatr Urol; 2015 Apr; 11(2):90.e1-5. PubMed ID: 25791422
[TBL] [Abstract][Full Text] [Related]
6. Intraureteral injection of NASHA/Dx gel under direct ureteroscopic visualization for the treatment of primary high-grade vesicoureteral reflux.
Mattioli G; Guida E; Rossi V; Podestà E; Jasonni V; Ghiggeri GM
J Laparoendosc Adv Surg Tech A; 2012 Oct; 22(8):844-7. PubMed ID: 22989035
[TBL] [Abstract][Full Text] [Related]
7. Treatment of pediatric vesicoureteral reflux using endoscopic injection of hyaluronic acid/dextranomer gel: intermediate-term experience by a single surgeon.
Hsieh MH; Madden-Fuentes RJ; Lindsay NE; Roth DR
Urology; 2010 Jul; 76(1):199-203. PubMed ID: 20035980
[TBL] [Abstract][Full Text] [Related]
8. Comparing treatment modalities for transplant kidney vesicoureteral reflux in the pediatric population.
Sheth KR; White JT; Stanasel I; Janzen N; Mittal A; Koh CJ; Austin PF; Roth DR; Tu DD; Gonzales ET; Ryan S; Jorgez C; Seth A
J Pediatr Urol; 2018 Dec; 14(6):554.e1-554.e6. PubMed ID: 30146426
[TBL] [Abstract][Full Text] [Related]
9. Comparison of results of endoscopic correction of vesicoureteral reflux in children using two bulking substances: Dextranomer/hyaluronic acid copolymer (Deflux) versus polyacrylate-polyalcohol copolymer (Vantris).
Warchol S; Krzemien G; Szmigielska A; Bombinski P; Brzewski M; Dudek-Warchol T
J Pediatr Urol; 2016 Aug; 12(4):256.e1-4. PubMed ID: 27593921
[TBL] [Abstract][Full Text] [Related]
10. Routine delayed voiding cystourethography after initial successful endoscopic treatment with Dextranomer/Hialuronic Acid Copolimer (Dx/HA) of vesicoureteral reflux (VUR). Is it necessary?
García-Aparicio L; Blázquez-Gómez E; Vila Santandreu A; Camacho Diaz JA; Vila-Cots J; Ramos Cebrian M; de Haro I; Martin O; Tarrado X
Actas Urol Esp; 2016 Dec; 40(10):635-639. PubMed ID: 27161091
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Subureteral Endoscopic Injection of Dextranomer/Hyaluronic Acid and Lich-Gregoir Ureteral Reimplantation in the Treatment of Pediatric Primary Vesicoureteral Reflux: A Prospective Randomized Study.
Salih EM; Eldamanhory H; Selmy GI; Galal HA
J Laparoendosc Adv Surg Tech A; 2021 Jun; 31(6):719-723. PubMed ID: 33751917
[No Abstract] [Full Text] [Related]
12. Randomized clinical trial between polyacrylate-polyalcohol copolymer (PPC) and dextranomer-hyaluronic acid copolymer (Dx/HA) as bulking agents for endoscopic treatment of primary vesicoureteral reflux (VUR).
García-Aparicio L; Blázquez-Gómez E; Martin O; Pérez-Bertólez S; Arboleda J; Soria A; Tarrado X
World J Urol; 2018 Oct; 36(10):1651-1656. PubMed ID: 29725806
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic treatment of grades IV and V vesicoureteral reflux with two bulking substances: Dextranomer hyaluronic acid copolymer versus polyacrylate polyalcohol copolymer in children.
Kocaoglu C
J Pediatr Surg; 2016 Oct; 51(10):1711-5. PubMed ID: 27117052
[TBL] [Abstract][Full Text] [Related]
14. Surgical Outcome Analysis of Pneumovesicoscopic Ureteral Reimplantation and Endoscopic Dextranomer/Hyaluronic Acid Injection for Primary Vesicoureteral Reflux in Children: A Multicenter 12-Year Review.
Chung KLY; Sihoe J; Liu K; Chao N; Hung J; Liu C; Yam F; Leung Y; Tam P; Lee KH; Leung M
J Laparoendosc Adv Surg Tech A; 2018 Mar; 28(3):348-353. PubMed ID: 29271690
[TBL] [Abstract][Full Text] [Related]
15. Minimally invasive treatment of vesicoureteral reflux with endoscopic injection of dextranomer/hyaluronic acid copolymer: the Children's Hospitals of Atlanta experience.
Kirsch AJ; Perez-Brayfield MR; Scherz HC
J Urol; 2003 Jul; 170(1):211-5. PubMed ID: 12796692
[TBL] [Abstract][Full Text] [Related]
16. Febrile urinary tract infections in children with an early negative voiding cystourethrogram after treatment of vesicoureteral reflux with dextranomer/hyaluronic acid.
Sedberry-Ross S; Rice DC; Pohl HG; Belman AB; Majd M; Rushton HG
J Urol; 2008 Oct; 180(4 Suppl):1605-9; discussion 1610. PubMed ID: 18710762
[TBL] [Abstract][Full Text] [Related]
17. The comparison of dextranomer/hyaluronic acid and polyacrylate-polyalcohol copolymers in endoscopic treatment of vesicoureteral reflux.
Karakus SC; User İR; Kılıc BD; Akçaer V; Ceylan H; Ozokutan BH
J Pediatr Surg; 2016 Sep; 51(9):1496-500. PubMed ID: 27061353
[TBL] [Abstract][Full Text] [Related]
18. The outcomes of two different bulking agents (dextranomer hyaluronic acid copolymer and polyacrylate-polyalcohol copolymer) in the treatment of primary vesico-ureteral reflux.
Taşkinlar H; Avlan D; Bahadir GB; Delibaş A; Nayci A
Int Braz J Urol; 2016; 42(3):514-20. PubMed ID: 27286115
[TBL] [Abstract][Full Text] [Related]
19. Endoscopic Injection of Dextranomer/Hyaluronic Acid as First Line Treatment in 851 Consecutive Children with High Grade Vesicoureteral Reflux: Efficacy and Long-Term Results.
Friedmacher F; Colhoun E; Puri P
J Urol; 2018 Sep; 200(3):650-655. PubMed ID: 29551405
[TBL] [Abstract][Full Text] [Related]
20. Treatment of vesicoureteral reflux in children using stabilized non-animal hyaluronic acid/dextranomer gel (NASHA/DX): a long-term observational study.
Stenberg A; Läckgren G
J Pediatr Urol; 2007 Apr; 3(2):80-5. PubMed ID: 18947708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
